Table of Contents 2
List of Tables 3
List of Figures 4
Report Guidance 5
GlobalData Clinical Trials Report Coverage 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 11
Top Five Countries Contributing to Clinical Trials in Europe 12
Top Countries Contributing to Clinical Trials in North America 13
Top Countries Contributing to Clinical Trials in Middle East and Africa 14
Top Five Countries Contributing to Clinical Trials in Central and South America 15
Clinical Trials by G7 Countries: Proportion of Diabetic Foot Infection (DFI) to Metabolic Disorders Clinical Trials 16
Clinical Trials by Phase in G7 Countries 18
Clinical Trials in G7 Countries by Trial Status 19
Clinical Trials by E7 Countries: Proportion of Diabetic Foot Infection (DFI) to Metabolic Disorders Clinical Trials 20
Clinical Trials by Phase in E7 Countries 22
Clinical Trials in E7 Countries by Trial Status 23
Clinical Trials by Phase 24
In Progress Trials by Phase 25
Clinical Trials by Trial Status 26
Clinical Trials by End Point Status 28
Subjects Recruited Over a Period of Time 29
Clinical Trials by Sponsor Type 30
Prominent Sponsors 31
Top Companies Participating in Diabetic Foot Infection (DFI) Therapeutics Clinical Trials 33
Prominent Drugs 35
Clinical Trial Profile Snapshots 36
Appendix 74
Abbreviations 74
Definitions 74
Research Methodology 75
Secondary Research 75
About GlobalData 75
Contact Us 76
Source 76

List of Tables
Diabetic Foot Infection (DFI) Therapeutics, Global, Clinical Trials by Region, 2018* 7
Diabetic Foot Infection (DFI) Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2018* 9
Diabetic Foot Infection (DFI) Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2018* 10
Diabetic Foot Infection (DFI) Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2018* 11
Diabetic Foot Infection (DFI) Therapeutics Clinical Trials, Europe, Top Five Countries, 2018* 12
Diabetic Foot Infection (DFI) Therapeutics Clinical Trials, North America, Top Countries, 2018* 13
Diabetic Foot Infection (DFI) Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2018* 14
Diabetic Foot Infection (DFI) Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2018* 15
Proportion of Diabetic Foot Infection (DFI) to Metabolic Disorders Clinical Trials, G7 Countries (%), 2018* 17
Diabetic Foot Infection (DFI) Therapeutics, G7 Countries, Clinical Trials by Phase, 2018* 18
Diabetic Foot Infection (DFI) Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2018* 19
Proportion of Diabetic Foot Infection (DFI) to Metabolic Disorders Clinical Trials, E7 Countries (%), 2018* 21
Diabetic Foot Infection (DFI) Therapeutics, E7 Countries, Clinical Trials by Phase, 2018* 22
Diabetic Foot Infection (DFI) Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2018* 23
Diabetic Foot Infection (DFI) Therapeutics, Global, Clinical Trials by Phase, 2018* 24
Diabetic Foot Infection (DFI) Therapeutics, Global, Clinical Trials In Progress by Phase 2018* 25
Diabetic Foot Infection (DFI) Therapeutics, Global, Clinical Trials by Trial Status, 2018* 27
Diabetic Foot Infection (DFI) Therapeutics Clinical Trials, Global, by End Point Status, 2018* 28
Diabetic Foot Infection (DFI) Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2013-2017 29
Diabetic Foot Infection (DFI) Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2018* 30
Diabetic Foot Infection (DFI) Therapeutics Clinical Trials, Global, Key Sponsors, 2018* 32
Diabetic Foot Infection (DFI) Therapeutics Clinical Trials, Global, Top Companies by Phase, 2018* 34
Diabetic Foot Infection (DFI) Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2018* 35

List of Figures
Diabetic Foot Infection (DFI) Therapeutics, Global, Clinical Trials by Region (%), 2018* 7
Diabetic Foot Infection (DFI) Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2018* 8
Diabetic Foot Infection (DFI) Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2018* 10
Diabetic Foot Infection (DFI) Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2018* 11
Diabetic Foot Infection (DFI) Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2018* 12
Diabetic Foot Infection (DFI) Therapeutics Clinical Trials, North America, Top Countries (%), 2018* 13
Diabetic Foot Infection (DFI) Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2018* 14
Diabetic Foot Infection (DFI) Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2018* 15
Proportion of Diabetic Foot Infection (DFI) to Metabolic Disorders Clinical Trials, G7 Countries (%), 2018* 16
Diabetic Foot Infection (DFI) Therapeutics, G7 Countries, Clinical Trials by Phase, 2018* 18
Diabetic Foot Infection (DFI) Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2018* 19
Proportion of Diabetic Foot Infection (DFI) to Metabolic Disorders Clinical Trials, E7 Countries (%), 2018* 20
Diabetic Foot Infection (DFI) Therapeutics, E7 Countries, Clinical Trials by Phase, 2018* 22
Diabetic Foot Infection (DFI) Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2018* 23
Diabetic Foot Infection (DFI) Therapeutics, Global, Clinical Trials by Phase (%), 2018* 24
Diabetic Foot Infection (DFI) Therapeutics, Global, Clinical Trials In Progress by Phase, 2018* 25
Diabetic Foot Infection (DFI) Therapeutics, Global, Clinical Trials by Trial Status, 2018* 26
Diabetic Foot Infection (DFI) Therapeutics Clinical Trials, Global, by End Point Status, 2018* 28
Diabetic Foot Infection (DFI) Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2013-2017 29
Diabetic Foot Infection (DFI) Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2018* 30
Diabetic Foot Infection (DFI) Therapeutics Clinical Trials, Global, Key Sponsors, 2018* 31
Diabetic Foot Infection (DFI) Therapeutics Clinical Trials, Global, Top Companies by Phase, 2018* 33
Diabetic Foot Infection (DFI) Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2018* 35
GlobalData Methodology 75

Companies Mentioned
- Merck & Co Inc
- TaiGen Biopharmaceuticals Holdings Ltd
- Innocoll AG
- Pfizer Inc
- PRA Health Sciences Inc
- Hetero Drugs Ltd
- Dipexium Pharmaceuticals Inc
- Basilea Pharmaceutica Ltd
- Amneal Pharmaceuticals Inc
- Allergan Plc